國立臺灣大學農藝學系Liu, Jen-PeiJen-PeiLiu2006-09-282018-07-112006-09-282018-07-112006http://ntur.lib.ntu.edu.tw//handle/246246/2006092815540131HER2 (the human epidermal growth factor receptor 2) is a member of the HER (erbB) family of transmembrane tyrosine kinase Enhanced level of HER2 is associated with mammary epithelial cell transformation and shorter survival in patients with breast cancer  25% of invasive breast cancers exhibit HER2 gene amplification The rate of HER2 gene amplification or protein in ductal carcinoma in situ (DCIS) is higher than invasive cancer  pathogenic role in the initiation of mammary carcinoma Treatment of Herceptin - requirement of screening the patients with over-expressed HER2 levelapplication/ppt1079808 bytesapplication/vnd.ms-powerpointzh-TW[SDGs]SDG3learning objecthttp://ntur.lib.ntu.edu.tw/bitstream/246246/2006092815540131/1/biotechnology11.ppt